000 02027nam  2200313za 4500
0019.843325
003CaOODSP
00520221107152511
007cr |||||||||||
008170911s2017    onca   #ob   f000 0 eng d
020 |a978-0-660-09587-5
040 |aCaOODSP|beng
043 |an-cn---
0861 |aHP45-17/2017E-PDF
24500|aCanadian biosafety guideline |h[electronic resource] : |bveterinary practices : physical design and operational practices for diagnostic activities.
24617|aVeterinary practices : |bphysical design and operational practices for diagnostic activities
260 |aOttawa : |bPublic Health Agency of Canada, |c2017.
300 |aviii, 32 p. : |bill.
500 |a"Publication date: September 2017."
500 |aTitle from cover.
500 |aIssued also in French under title: Ligne directrice canadienne sur la biosécurité : conception physique et pratiques opérationnelles dans le cadre d’activités de diagnostic en établissement vétérinaire.
504 |aIncludes bibliographical references.
520 |a"In Canada, facilities where Risk Group 2, 3, and 4 human pathogens or toxins are handled and stored are regulated by the Public Health Agency of Canada (PHAC) under the Human Pathogens and Toxins Act (HPTA) and the Human Pathogens and Toxins Regulations (HPTR). The importation of animal pathogens, infected animals, animal products or by-products (e.g., tissue, serum), or other substances that may carry an animal pathogen or toxin or parts thereof are regulated by the PHAC or the Canadian Food Inspection Agency (CFIA) under the Health of Animals Act (HAA) and Health of Animals Regulations (HAR)"--Preface.
69207|2gccst|aTissues
69207|2gccst|aAnimal research
69207|2gccst|aSafety measures
7102 |aPublic Health Agency of Canada.
77508|tLigne directrice canadienne sur la biosécurité |w(CaOODSP)9.843328
85640|qPDF|s3.60 MB|uhttps://publications.gc.ca/collections/collection_2018/aspc-phac/HP45-17-2017-eng.pdf